Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.7
9.42
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one FF stock under the Base Case scenario is 16.52 EUR. Compared to the current market price of 8.22 EUR, Fine Foods & Pharmaceuticals NTM SpA is Undervalued by 50%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Fine Foods & Pharmaceuticals NTM SpA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for FF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Fine Foods & Pharmaceuticals NTM SpA
Balance Sheet Decomposition
Fine Foods & Pharmaceuticals NTM SpA
Current Assets | 106.4m |
Cash & Short-Term Investments | 18.7m |
Receivables | 42.3m |
Other Current Assets | 45.3m |
Non-Current Assets | 133.5m |
PP&E | 115m |
Intangibles | 13.1m |
Other Non-Current Assets | 5.3m |
Current Liabilities | 67.6m |
Accounts Payable | 33.2m |
Accrued Liabilities | 29.2k |
Other Current Liabilities | 34.4m |
Non-Current Liabilities | 43.8m |
Long-Term Debt | 41.4m |
Other Non-Current Liabilities | 2.4m |
Earnings Waterfall
Fine Foods & Pharmaceuticals NTM SpA
Revenue
|
371m
EUR
|
Cost of Revenue
|
-260.8m
EUR
|
Gross Profit
|
110.2m
EUR
|
Operating Expenses
|
-93.3m
EUR
|
Operating Income
|
16.9m
EUR
|
Other Expenses
|
-11.5m
EUR
|
Net Income
|
5.3m
EUR
|
Free Cash Flow Analysis
Fine Foods & Pharmaceuticals NTM SpA
EUR | |
Free Cash Flow | EUR |
FF Profitability Score
Profitability Due Diligence
Fine Foods & Pharmaceuticals NTM SpA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Fine Foods & Pharmaceuticals NTM SpA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
FF Solvency Score
Solvency Due Diligence
Fine Foods & Pharmaceuticals NTM SpA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Fine Foods & Pharmaceuticals NTM SpA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FF Price Targets Summary
Fine Foods & Pharmaceuticals NTM SpA
According to Wall Street analysts, the average 1-year price target for FF is 12.5 EUR with a low forecast of 12.12 EUR and a high forecast of 13.13 EUR.
Dividends
Current shareholder yield for FF is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 768 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
Contact
IPO
Employees
Officers
The intrinsic value of one FF stock under the Base Case scenario is 16.52 EUR.
Compared to the current market price of 8.22 EUR, Fine Foods & Pharmaceuticals NTM SpA is Undervalued by 50%.